Aug 29, 2018· Comment from Association for Accessible Medicines (AAM)· FDA-2018-D-1043-0007
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2018-D-1043
Waivers of the Single, Shared System Risk Evaluation and Mitigation Strategy Requirement
RIN
—
Last modified
Aug 31, 2018
Comment window
closed 2889d ago
Association for Accessible Medicines filings
1
Activity
Association for Accessible Medicines filed 1 comment on this docket between Aug 29, 2018 and Aug 29, 2018. 6 other organizations filed here. The comment window closed 2889d ago.
What Association for Accessible Medicines filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (6)
See everyone who commented →- Association for Accessible MedicinesTHIS ORG1 filing · confidence 97%
- Aimed Alliancetrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- Leukemia & Lymphoma Societytrade assoc.1 filing · confidence 85%
- National Association of Chain Drug Storestrade assoc.1 filing · confidence 97%
- Perrigo Company Plcunverified attribution1 filing · confidence 70%
- Pharmaceutical Care Management Associationtrade assoc.1 filing · confidence 85%